Development and Market Expansion Strategy of Jinjia Group's Tobacco Business

Business by 2FIRSTS.ai

Nov.17.2023

Development and Market Expansion Strategy of Jinjia Group's Tobacco Business

Shenzhen Jingjia Group completed an investor relation event on Nov 15, focusing on Philip Morris' tobacco business and smokeless development plans.

On November 15th, Shenzhen Jingjia Group Co., Ltd. (Jingjia Company) conducted an investor relations event. During the event, investors showed interest in Philip Morris International's (PMI) new tobacco business and inquired about Jingjia Company's plans for the development of non-combustible products.

In response, Jingjia Corporation stated that the main services provided to customers include ODM/OEM services for new tobacco products such as e-cigarettes, as well as the research, production, and sales of vape oil, HNB flavorings, related supporting materials. Additionally, the company will also focus on the construction of overseas channels for new tobacco and brand promotion, striving to achieve a greater market share in this sector.

References:

[1] 劲嘉股份(002191):2023年11月15日投资者关系活动记录表

Also Read:

[1] Tobacco Licenses Obtained by Jingjia Holdings' Subsidiaries

[2] Jinjia Group: Business Declining while Diversifying into New Materials

[3] Jinjia Establishes Subsidiary for Electronic Materials Development

#E-cigarette Market #USA #jinjia

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia

The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.

Dec.10 by 2FIRSTS.ai

Call2Recycle Expands Vape Recycling in Canada, Bringing Cannabis Devices Into Quebec-Wide Program

Call2Recycle Canada, the country’s battery stewardship organization, is expanding its vape recycling program in Quebec to include cannabis vape devices, strengthening the safe recovery of embedded batteries and device materials. Backed by government bodies, producers and other stakeholders, the initiative aims to reduce landfill waste and create a scalable model for other Canadian provinces.

Dec.03 by 2FIRSTS.ai

Special Report｜ Vuse Gains as U.S. Cracks Down on Illegal Vapes, But a $590 Million China Export Shadow Looms

The payoff is here: BAT’s Vuse has seized a rare regulatory vacuum to reverse its U.S. slide, capitalizing on a crackdown that seemingly compressed the illicit market to 54%. But the victory is fragile. A record $590 million export shock in October signals the gray market is striking back—pitting a fleeting compliance dividend against a massive inventory wall.